• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Although the treatment of myocardial infarction (MI) has improved considerably, it is still a
worldwide disease with high morbidity and high mortality. Whilst there is still a long way to …

2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

Understanding the natural history of coronary artery atherosclerosis is necessary to
determine prognosis and prescribe effective therapies. Traditional management of coronary …

Task Force structure and summary of clinical evidence of 2022 ESC/EACTS review of the
2018 guideline recommendations on the revascularization of left main coronary artery …

Artificial intelligence is a science that is growing at a tremendous speed every day and has
become an essential part of many domains, including the medical domain. Therefore …

Background The first coronary artery bypass operation (CABG) was performed on May 2,
1960. The first percutaneous coronary intervention (PCI) was performed almost 20 years …

Aims An observational nationwide all-comers prospective register study to analyse
outcomes after coronary artery bypass grafting (CABG) or percutaneous coronary …

Importance Patients with left main coronary artery disease presenting with an acute coronary
syndrome (ACS) represent a high-risk and understudied subgroup of patients with …

Stable coronary artery disease (CAD) has recently been replaced by a new entity described
as chronic coronary syndrome (CCS). This new entity has been developed based on a …